Drug Profile
Research programme: anti-interleukin-1 antibody - Roche
Alternative Names: 35F5Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Roche
- Class Antibodies
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in United Kingdom (IV)
- 21 May 2008 Preclinical trials in Viral infections in United Kingdom (IV)
- 21 May 2008 Preclinical pharmacodynamics data from a trial in COPD-like viral exacerbation presented at the 104th International Conference of the American Thoracic Society (ATS-2008)